{"result":[{"lastName":"Fisher","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4644&type=small&showNoImage","displayName":"George A. Fisher Jr.","firstName":"George","href":"http://med.stanford.edu/profiles/cancer/researcher/George_Fisher","researchInterest":"Clinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials."},{"lastName":"Koong","clinicalFocus":[{"focus":"Pancreatic Cancer "},{"focus":"Pancreatic Cancer - Radiation Oncology"},{"focus":"Rectal Cancer - Radiation Oncology"},{"focus":"Liver Cancer - Radiation Oncology"},{"focus":"Stomach Cancer - Radiation Oncology"},{"focus":"Esophageal Cancer - Radiation Oncology"},{"focus":"Colorectal Cancer - Radiation Oncology"},{"focus":"Radiation Oncology"}],"appointments":[{"appointment":"Associate Professor,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor,Radiation Oncology - Radiation Therapy","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4729&type=small&showNoImage","displayName":"Albert Koong","firstName":"Albert","href":"http://med.stanford.edu/profiles/cancer/researcher/Albert_Koong","researchInterest":"The focus of my laboratory is to understand the role of hypoxia and the tumor microenvironment on malignant progression. My clinical area of interest is in the application of chemoradiotherapy and stereotactic body radiotherapy (SBRT) for GI malignancies."},{"lastName":"Blayney","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Cancer Survivorship"},{"focus":"Breast cancer"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=18330&type=small&showNoImage","displayName":"Douglas W. Blayney","firstName":"Douglas","href":"http://med.stanford.edu/profiles/cancer/researcher/Douglas_Blayney","researchInterest":"Use of medical informatics to improve quality delivery in cancer care"},{"lastName":"Telli","clinicalFocus":[{"focus":"Breast Cancer - Medical Oncology"},{"focus":"Triple-negative breast cancer"},{"focus":"Locally advanced breast cancer"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8521&type=small&showNoImage","displayName":"Melinda L. Telli, M.D.","firstName":"Melinda","href":"http://med.stanford.edu/profiles/cancer/researcher/Melinda_Telli","researchInterest":"My research focuses on breast cancer treatment and survivorship. My primary research interest is the development of novel strategies for the treatment of early stage triple-negative and BRCA1/2 mutation-associated breast cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents."},{"lastName":"Dirbas","clinicalFocus":[{"focus":"General Surgery"},{"focus":"Accelerated Breast Radiation"},{"focus":"MRI in Breast Cancer Staging"},{"focus":"Minimally Invasive Breast Surgery"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4667&type=small&showNoImage","displayName":"Frederick M. Dirbas","firstName":"Frederick","href":"http://med.stanford.edu/profiles/cancer/researcher/Frederick_Dirbas","researchInterest":"My research interests are focused on minimizing the impact of breast cancer from a diagnostic and therapuetic standpoint. Breast MRI is a powerful tool to facilitate the screening for and staging of breast cancer, and can be valuable adjunct to guide breast surgery. Oncoplastic surgical techniques optimize cosmesis after breast cancer surgery. Accelerated radiotherapy after lumpectomy decreases radiotherapy treatment times from 6 weeks to just 1 to 5 days."},{"lastName":"Swetter","clinicalFocus":[{"focus":"Pigmented Skin Lesions"},{"focus":"Melanoma"},{"focus":"Skin Cancer "},{"focus":"Basal/ Squamous Cell Carcinomas - VA Dermatology"},{"focus":"Dermatology"},{"focus":"Cutaneous Oncology"},{"focus":"Basal / Squamous Cell Carcinomas - Dermatology"},{"focus":"Pigmented Lesion and Melanoma Program"},{"focus":"Melanoma - Dermatology"},{"focus":"Pigmented Skin Lesions - Dermatology"},{"focus":"Pigmented Skin Lesions - Medical Oncology"},{"focus":"Skin Cancer - Dermatology"}],"appointments":[{"appointment":"Professor - Med Center Line,Dermatology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Dermatology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4215&type=small&showNoImage","displayName":"Susan Swetter, M.D.","firstName":"Susan","href":"http://med.stanford.edu/profiles/cancer/researcher/Susan_Swetter","researchInterest":"1) Early detection of melanoma through enhanced screening and professional and public education to improve melanoma awareness. 2) Chemoprevention of melanoma and nonmelanoma skin cancers in high-risk groups. 4) Epidemiologic and sociodemographic aspects of melanoma. 4) National dermatologist liaison to the ECOG Melanoma Committee and Co-founder/Co-Director of the Melanoma Prevention Working Group, an interdisciplinary Intergroup collaboration dedicated to melanoma control and prevention"},{"lastName":"Witteles","clinicalFocus":[{"focus":"Heart Failure"},{"focus":"Amyloidosis"},{"focus":"Cardiotoxicity of Cancer Therapies"},{"focus":"Cardiovascular Disease"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Cardiovascular Medicine"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Cardiovascular Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8212&type=small&showNoImage","displayName":"Ronald Witteles","firstName":"Ronald","href":"http://med.stanford.edu/profiles/cancer/researcher/Ronald_Witteles","researchInterest":"1) Understanding, treating, and preventing cancer therapy-induced cardiotoxicity\r\n2) Amyloidosis -- Optimizing therapy and discovering new treatments\r\n3) Relationships between insulin resistance and dilated cardiomyopathy"},{"lastName":"Horst","clinicalFocus":[{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Radiation Oncology"},{"focus":"Breast Cancer - Partial Breast Irradiation"},{"focus":"Radiation Oncology"},{"focus":"Radiation Therapy"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Radiation Oncology - Radiation Therapy","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6053&type=small&showNoImage","displayName":"Kathleen Horst","firstName":"Kathleen","href":"http://med.stanford.edu/profiles/cancer/researcher/Kathleen_Horst","researchInterest":""},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4131&type=small&showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://med.stanford.edu/profiles/cancer/researcher/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Jeffrey","clinicalFocus":[{"focus":"General Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4147&type=small&showNoImage","displayName":"Stefanie S. Jeffrey, MD","firstName":"Stefanie","href":"http://med.stanford.edu/profiles/cancer/researcher/Stefanie_Jeffrey","researchInterest":"Dr. Jeffrey was team leader of the multidisciplinary team from the School of Medicine, School of Engineering, and Genome Technology Center that invented the MagSweeper automated technology to isolate live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis. Her lab characterizes CTCs in different cancers, investigating CTC profiles and mutations as potential companion diagnostics to define individual patient response to newer biologically-based cancer therapies."},{"lastName":"Wapnir","clinicalFocus":[{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Surgery"},{"focus":"Breast Surgery"},{"focus":"General Surgery"},{"focus":"Nipple-sparing mastectomy, breast conserving surgery, sentinel node biopsy"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4337&type=small&showNoImage","displayName":"Irene Wapnir","firstName":"Irene","href":"http://med.stanford.edu/profiles/cancer/researcher/Irene_Wapnir","researchInterest":"Clinical treatment trials in Breast Cancer, especially local recurrence of breast cancer. Dr. Wapnir is institutional Principal Investigator for National Surgical Adjuvant Breast and Bowel Project (NSABP). Laboratory research includes exploring the activity of breast iodide transporter in breast cancer. These endeavors have lead to translational research protocols."},{"lastName":"Allison","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=37019&type=small&showNoImage","displayName":"Kimberly Allison","firstName":"Kimberly","href":"http://med.stanford.edu/profiles/cancer/researcher/Kimberly_Allison","researchInterest":"Dr. Allison\u0092s clinical expertise is in breast pathology.  Her research interests include how standards should be applied to breast cancer diagnostics (such as HER2 testing), the utility of molecular panel-based testing in breast cancer, and identifying the most appropriate management of specific pathologic diagnoses. She is also the author of \u0093Red Sunshine\u0094, a memoir about her personal experience with breast cancer, a topic which she speaks about to both patient and health care audiences."},{"lastName":"Goodman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - General Medical Disciplines"},{"appointment":"Professor,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Professor,Medicine - General Medical Disciplines","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23410&type=small&showNoImage","displayName":"Steven Goodman","firstName":"Steven","href":"http://med.stanford.edu/profiles/cancer/researcher/Steven_Goodman","researchInterest":"I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research. Finally, I have an ongoing project related to landmark clinical trials that have had great impact."},{"lastName":"Jensen","clinicalFocus":[{"focus":"Pathology"},{"focus":"Cytopathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7660&type=small&showNoImage","displayName":"Kristin Jensen","firstName":"Kristin","href":"http://med.stanford.edu/profiles/cancer/researcher/Kristin_Jensen","researchInterest":"I am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/cancer/researcher/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Pegram","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=32170&type=small&showNoImage","displayName":"Mark Pegram","firstName":"Mark","href":"http://med.stanford.edu/profiles/cancer/researcher/Mark_Pegram","researchInterest":""},{"lastName":"Link","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics - Hematology & Oncology"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Pediatrics - Hematology & Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4631&type=small&showNoImage","displayName":"Michael Link","firstName":"Michael","href":"http://med.stanford.edu/profiles/cancer/researcher/Michael_Link","researchInterest":"Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease."},{"lastName":"Sledge","clinicalFocus":[],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=38346&type=small&showNoImage","displayName":"George W. Sledge Jr., M.D.","firstName":"George","href":"http://med.stanford.edu/profiles/cancer/researcher/George_Sledge","researchInterest":""},{"lastName":"Liang","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Medicine"}],"primaryAppointment":"Postdoctoral Research fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=37890&type=small&showNoImage","displayName":"Ying Liang,MD,PHD","firstName":"Ying","href":"http://med.stanford.edu/profiles/postdocs/researcher/Ying_Liang","researchInterest":"My clinical and research interest is to apply evolving technologies to the diagnosis, characterization, and individualized treatment of Thoracic cancer such as NSCLC, SCLC, Thymoma,Mesothelioma."},{"lastName":"Horn-Ross","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7424&type=small&showNoImage","displayName":"Pamela Horn-Ross","firstName":"Pamela","href":"http://med.stanford.edu/profiles/cancer/researcher/Pamela_Horn-Ross","researchInterest":"My research interests focus on nutrition and the etiology of hormonally-dependent cancers in women (most particularly breast, endometrial, and thyroid cancers).  Of particular interest are the effects of phytochemicals that may reduce cancer risk, such as the isoflavones in soy foods, the lignans in whole grains, the isothiocyanates in broccoli and other cruciferous vegetables, and resveratrol in red wine and peanuts. Nutrient-gene interactions are also of interest."},{"lastName":"Kurian","clinicalFocus":[{"focus":"Cancer Genetics"},{"focus":"Medical Oncology"},{"focus":"Breast Cancer Risk"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Assistant Professor - Med Center Line,Health Research & Policy"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6431&type=small&showNoImage","displayName":"Allison W. Kurian, M.D., M.Sc.","firstName":"Allison","href":"http://med.stanford.edu/profiles/cancer/researcher/Allison_Kurian","researchInterest":"Breast and gynecologic cancer genetics, epidemiology, prevention, and outcomes."},{"lastName":"Clarke","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7430&type=small&showNoImage","displayName":"Christina Clarke","firstName":"Christina","href":"http://med.stanford.edu/profiles/cancer/researcher/Christina_Clarke","researchInterest":"Dr. Clarke\u0092s research efforts are centered in five areas: 1) the epidemiology of breast cancer, 2) the epidemiology of lymphoid malignancies 3) immunologic and viral causes of malignancy, and 4) cancer surveillance and creative uses of and ways to visually display cancer surveillance data (e.g, SEER, cancer registry data) and more recently, 5) internet-based, patient-centric methods for recruitment and data collection in epidemiologic studies."},{"lastName":"Colevas","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"developmental therapeutics"},{"focus":"investigational new drugs"},{"focus":"Adverse event( toxicity) evaluation and reporting"},{"focus":"Thyroid Cancer"},{"focus":"combined chemotherapy and radiation treatment"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Associate Professor - Med Center Line (By courtesy),Otolaryngology (Head and Neck Surgery)"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8044&type=small&showNoImage","displayName":"Alexander Colevas","firstName":"Alexander","href":"http://med.stanford.edu/profiles/cancer/researcher/Alexander_Colevas","researchInterest":"Multi- modality treatment of Head and Neck Cancer\r\n\r\nPhase 1 clinical trials"},{"lastName":"Marina","clinicalFocus":[{"focus":"Soft Tissue Sarcoma"},{"focus":"sarcomas"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pediatrics - Hematology & Oncology"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Pediatrics - Hematology & Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4473&type=small&showNoImage","displayName":"Neyssa Marina","firstName":"Neyssa","href":"http://med.stanford.edu/profiles/cancer/researcher/Neyssa_Marina","researchInterest":"Germ cell tumors and bone sarcomas."},{"lastName":"Ganjoo","clinicalFocus":[{"focus":"Oncology"},{"focus":"Soft Tissue Sarcoma"},{"focus":"Gastrointestinal Stromal Tumors"},{"focus":"Ewing's Sarcoma"},{"focus":"Osteosarcoma"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6696&type=small&showNoImage","displayName":"Kristen N Ganjoo","firstName":"Kristen","href":"http://med.stanford.edu/profiles/cancer/researcher/Kristen_Ganjoo","researchInterest":"Non-Hodgkin's Lymphoma;\r\nSoft tissue sarcoma;\r\nOsteosarcoma."}]}